The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population
After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a single...
Gespeichert in:
Veröffentlicht in: | Journal of clinical pharmacology 1989-01, Vol.29 (1), p.25-32 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 32 |
---|---|
container_issue | 1 |
container_start_page | 25 |
container_title | Journal of clinical pharmacology |
container_volume | 29 |
creator | Cummings, Doyle M. Amadio Jr, Peter Taylor Jr, Elmer J. Balaban, Donald J. Rocci Jr, Mario L. Abrams, William B. Feinberg, Jerry Vlasses, Peter H. |
description | After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension. |
doi_str_mv | 10.1002/j.1552-4604.1989.tb03233.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78942642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78942642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</originalsourceid><addsrcrecordid>eNqVkF1v0zAUhi0EGt3gJyBZCHGX4K84ya7oqn0wVaOgARI3luMcM3epHeJ0a_89iRr1nitbep_z-vhB6D0lKSWEfVqnNMtYIiQRKS2LMu0rwhnn6e4Fmh2jl2hGSEkTlhPyGp3GuCaESpHRE3TCMkEYEzNU3T8AnvvePexb6Hrw0T0B_g6xDT4C7gNeuuh8aDvXnOMRvrQWTI-DxfM_gJ3HGq86qMPGee37Zo8vGm0e8Sq020b3Lvg36JXVTYS303mGflxd3i9ukuXX6y-L-TIxghc80SKzwAkrJKuEzbjURQVSC6i0FAXlYGuTCSm0rI0GkktqTFnyoioNl3UB_Ax9PPS2Xfi7hdirjYsGmkZ7CNuo8qIUTAo2gOcH0HQhxg6sGn630d1eUaJGwWqtRotqtKhGwWoSrHbD8LvplW21gfo4Ohkd8g9TrqPRje20Ny4eMSmLrGTlgH0-YM-ugf1_LKBuF6ub8TpUJIcKF3vYHSt096hkzvNM_bq7VpyJbz9_X1C14v8AlpWnyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78942642</pqid></control><display><type>article</type><title>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cummings, Doyle M. ; Amadio Jr, Peter ; Taylor Jr, Elmer J. ; Balaban, Donald J. ; Rocci Jr, Mario L. ; Abrams, William B. ; Feinberg, Jerry ; Vlasses, Peter H.</creator><creatorcontrib>Cummings, Doyle M. ; Amadio Jr, Peter ; Taylor Jr, Elmer J. ; Balaban, Donald J. ; Rocci Jr, Mario L. ; Abrams, William B. ; Feinberg, Jerry ; Vlasses, Peter H.</creatorcontrib><description>After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.</description><identifier>ISSN: 0091-2700</identifier><identifier>EISSN: 1552-4604</identifier><identifier>DOI: 10.1002/j.1552-4604.1989.tb03233.x</identifier><identifier>PMID: 2540224</identifier><identifier>CODEN: JCPCBR</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; African Continental Ancestry Group ; Aged ; Aged, 80 and over ; Aging - physiology ; Aldosterone - blood ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive agents ; Biological and medical sciences ; Cardiovascular system ; Enalapril - adverse effects ; Enalapril - analogs & derivatives ; Enalapril - therapeutic use ; Female ; Humans ; Hydrochlorothiazide - therapeutic use ; Hypertension - drug therapy ; Lisinopril ; Male ; Medical sciences ; Middle Aged ; Peptidyl-Dipeptidase A - blood ; Pharmacology. Drug treatments ; Potassium - blood ; Renin - blood</subject><ispartof>Journal of clinical pharmacology, 1989-01, Vol.29 (1), p.25-32</ispartof><rights>1989 American College of Clinical Pharmacology</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</citedby><cites>FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fj.1552-4604.1989.tb03233.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fj.1552-4604.1989.tb03233.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,4010,27900,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6685929$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2540224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cummings, Doyle M.</creatorcontrib><creatorcontrib>Amadio Jr, Peter</creatorcontrib><creatorcontrib>Taylor Jr, Elmer J.</creatorcontrib><creatorcontrib>Balaban, Donald J.</creatorcontrib><creatorcontrib>Rocci Jr, Mario L.</creatorcontrib><creatorcontrib>Abrams, William B.</creatorcontrib><creatorcontrib>Feinberg, Jerry</creatorcontrib><creatorcontrib>Vlasses, Peter H.</creatorcontrib><title>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</title><title>Journal of clinical pharmacology</title><addtitle>J Clin Pharmacol</addtitle><description>After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.</description><subject>Adult</subject><subject>African Continental Ancestry Group</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging - physiology</subject><subject>Aldosterone - blood</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Enalapril - adverse effects</subject><subject>Enalapril - analogs & derivatives</subject><subject>Enalapril - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Hydrochlorothiazide - therapeutic use</subject><subject>Hypertension - drug therapy</subject><subject>Lisinopril</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peptidyl-Dipeptidase A - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium - blood</subject><subject>Renin - blood</subject><issn>0091-2700</issn><issn>1552-4604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF1v0zAUhi0EGt3gJyBZCHGX4K84ya7oqn0wVaOgARI3luMcM3epHeJ0a_89iRr1nitbep_z-vhB6D0lKSWEfVqnNMtYIiQRKS2LMu0rwhnn6e4Fmh2jl2hGSEkTlhPyGp3GuCaESpHRE3TCMkEYEzNU3T8AnvvePexb6Hrw0T0B_g6xDT4C7gNeuuh8aDvXnOMRvrQWTI-DxfM_gJ3HGq86qMPGee37Zo8vGm0e8Sq020b3Lvg36JXVTYS303mGflxd3i9ukuXX6y-L-TIxghc80SKzwAkrJKuEzbjURQVSC6i0FAXlYGuTCSm0rI0GkktqTFnyoioNl3UB_Ax9PPS2Xfi7hdirjYsGmkZ7CNuo8qIUTAo2gOcH0HQhxg6sGn630d1eUaJGwWqtRotqtKhGwWoSrHbD8LvplW21gfo4Ohkd8g9TrqPRje20Ny4eMSmLrGTlgH0-YM-ugf1_LKBuF6ub8TpUJIcKF3vYHSt096hkzvNM_bq7VpyJbz9_X1C14v8AlpWnyw</recordid><startdate>198901</startdate><enddate>198901</enddate><creator>Cummings, Doyle M.</creator><creator>Amadio Jr, Peter</creator><creator>Taylor Jr, Elmer J.</creator><creator>Balaban, Donald J.</creator><creator>Rocci Jr, Mario L.</creator><creator>Abrams, William B.</creator><creator>Feinberg, Jerry</creator><creator>Vlasses, Peter H.</creator><general>Blackwell Publishing Ltd</general><general>Sage Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198901</creationdate><title>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</title><author>Cummings, Doyle M. ; Amadio Jr, Peter ; Taylor Jr, Elmer J. ; Balaban, Donald J. ; Rocci Jr, Mario L. ; Abrams, William B. ; Feinberg, Jerry ; Vlasses, Peter H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4383-a45fe302862b4f536a8be6a4eba64813efdc5464a6dcae0761cc9938b9c36d8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>African Continental Ancestry Group</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging - physiology</topic><topic>Aldosterone - blood</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Enalapril - adverse effects</topic><topic>Enalapril - analogs & derivatives</topic><topic>Enalapril - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Hydrochlorothiazide - therapeutic use</topic><topic>Hypertension - drug therapy</topic><topic>Lisinopril</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peptidyl-Dipeptidase A - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium - blood</topic><topic>Renin - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cummings, Doyle M.</creatorcontrib><creatorcontrib>Amadio Jr, Peter</creatorcontrib><creatorcontrib>Taylor Jr, Elmer J.</creatorcontrib><creatorcontrib>Balaban, Donald J.</creatorcontrib><creatorcontrib>Rocci Jr, Mario L.</creatorcontrib><creatorcontrib>Abrams, William B.</creatorcontrib><creatorcontrib>Feinberg, Jerry</creatorcontrib><creatorcontrib>Vlasses, Peter H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cummings, Doyle M.</au><au>Amadio Jr, Peter</au><au>Taylor Jr, Elmer J.</au><au>Balaban, Donald J.</au><au>Rocci Jr, Mario L.</au><au>Abrams, William B.</au><au>Feinberg, Jerry</au><au>Vlasses, Peter H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population</atitle><jtitle>Journal of clinical pharmacology</jtitle><addtitle>J Clin Pharmacol</addtitle><date>1989-01</date><risdate>1989</risdate><volume>29</volume><issue>1</issue><spage>25</spage><epage>32</epage><pages>25-32</pages><issn>0091-2700</issn><eissn>1552-4604</eissn><coden>JCPCBR</coden><abstract>After a 2–4 week no‐treatment period, 24 patients (12 young, age 29–45 yr.; 12 elderly, age 65–81 yr.; 20 black, 4 white) with an untreated sitting diastolic blood pressure between 91–120 mm Hg received the nonsulfhydryl angiotensin converting enzyme inhibitor, lisinopril for three weeks in a singleblind, parallel group comparison. Patients who did not achieve goal blood pressure with the initial low‐dose (10 mg/day) were treated with a high‐dose regimen (40 mg/day) for three weeks. In those who remained incompletely responsive, hydrochlorothiazide 25 mg/day was added for four weeks in an attempt to normalize blood pressure (≤90 mm Hg). Low‐dose lisinopril monotherapy produced comparable reductions in the mean systolic and diastolic blood pressures (approximately −15/−8 mm Hg in both younger and older patients). Increasing the dose produced a slightly greater fall in mean blood pressures which normalized the blood pressure in five of six elderly patients unresponsive to the lower dose; addition of hydrochlorothiazide normalized three of the five remaining subjects from both groups who were unresponsive to high dose lisinopril. Lisinopril administration resulted in a rise in plasma renin activity and a fall in plasma aldosterone concentrations which were similar in both groups and which returned over time toward the baseline. The drug was well tolerated, producing one episode of symptomatic hypotension following the addition of hydrochlorothiazide to lisinopril monotherapy. Lisinopril alone or in combination with hydrochlorothiazide produces favorable antihypertensive effects in both younger and older predominantly black, low‐renin patients with essential hypertension.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2540224</pmid><doi>10.1002/j.1552-4604.1989.tb03233.x</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-2700 |
ispartof | Journal of clinical pharmacology, 1989-01, Vol.29 (1), p.25-32 |
issn | 0091-2700 1552-4604 |
language | eng |
recordid | cdi_proquest_miscellaneous_78942642 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult African Continental Ancestry Group Aged Aged, 80 and over Aging - physiology Aldosterone - blood Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive agents Biological and medical sciences Cardiovascular system Enalapril - adverse effects Enalapril - analogs & derivatives Enalapril - therapeutic use Female Humans Hydrochlorothiazide - therapeutic use Hypertension - drug therapy Lisinopril Male Medical sciences Middle Aged Peptidyl-Dipeptidase A - blood Pharmacology. Drug treatments Potassium - blood Renin - blood |
title | The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A45%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Antihypertensive%20Response%20to%20Lisinopril:%20The%20Effect%20of%20Age%20in%20a%20Predominantly%20Black%20Population&rft.jtitle=Journal%20of%20clinical%20pharmacology&rft.au=Cummings,%20Doyle%20M.&rft.date=1989-01&rft.volume=29&rft.issue=1&rft.spage=25&rft.epage=32&rft.pages=25-32&rft.issn=0091-2700&rft.eissn=1552-4604&rft.coden=JCPCBR&rft_id=info:doi/10.1002/j.1552-4604.1989.tb03233.x&rft_dat=%3Cproquest_cross%3E78942642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78942642&rft_id=info:pmid/2540224&rfr_iscdi=true |